Earn Extra Credit by Attending Mayo Clinic Laboratories’ Hematology Conferences
On Oct. 6‒8, 2021, Mayo Clinic Laboratories is hosting its 17th Bleeding and Thrombosing Diseases Conference and Workshop, and on Oct. 8-9, 2021, we’re also hosting a Non-Malignant Hematology Conference. Both conferences will be live-streamed online.
With a mix of presentations supplemented by panel discussions and case studies, our Bleeding and Thrombosing Diseases Conference and Workshop will provide attendees with reviews and updates on current laboratory and clinical aspects of bleeding and thrombosing disorders.
Click here for more information about this conference, including continuing education credit eligibility.
Our Non-Malignant Hematology Conference will look at the best ways to interpret and apply standard and evolving testing methods for diagnosing non-malignant blood disorders. This conference will also highlight the testing algorithms we use here at MCL and the different ways that unnecessary, redundant, and costly laboratory tests can be eliminated while still maintaining high-quality patient care.
Click here for more information about our Non-Malignant Hematology Conference, including continuing education credit eligibility.
At the end of both conferences, all participants should be able to:
- Summarize clinical features and laboratory evaluation of congenital and acquired bleeding disorders, including hemophilia A and B, hereditary platelet disorders, and von Willebrand disease.
- Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia, lupus anticoagulant, and antiphospholipid syndrome.
- Explain key features of treatment of venous thromboembolism (VTE) including options for therapy and care for specialized patient populations with VTE (i.e., cancer patients).
- Discuss features of the direct oral anticoagulant (DOAC) drugs including situations where use is appropriate versus not recommended, and options for DOAC reversal.
- Recognize the clinical presentation of rare bone marrow failure syndromes.
- Describe the algorithmic strategy for the diagnostic workup of various red blood cell, white blood cell and platelet disorders.
- Discuss recent advances in the management of these disorders.
Conference Fees and Registration
2021 Bleeding and Thrombosing Diseases Conference and Workshop (livestream):
Residents/Fellows/Allied Health: $450
Attendees who also register for the Non-Malignant Hematology Conference are eligible for a $100 credit toward the price of the Bleeding and Thrombosing Diseases Conference and Workshop. Please contact email@example.com or call 507-284-3156 to redeem this credit.
2021 Non-Malignant Hematology Conference (livestream):
Residents/Fellows/Allied Health: $200
For questions or more information about these conferences, contact us at firstname.lastname@example.org.